Search
Showing results for "1"
Research
Prevalence of tracheobronchomalacia is higher than previously reported in children with cystic fibrosisTracheobronchomalacia (TBM) is estimated to be present in 1 in 2100 children. Previous reports suggest the prevalence is higher in children with cystic fibrosis (CF). This has clinical implications with potential to influence airway clearance and lung health.

News & Events
Starting young on diabetes researchKalani Hancock (1) and her sister Avalee (4) are part of a world-first study looking at changes in blood sugar patterns in very young children at risk of Diabetes. Dr Aveni Haynes from The Kids Research Institute Australia and Perth Children's Hospital is part of the team leading this ground breaking study.

News & Events
Research roundupTake a look at some of the published research to come out of the Children's Diabetes Centre recently.

News & Events
Leeuwin adventure a real hitDuring the school holidays, Diabetes WA supported three young adults to join the Leeuwin Ocean Adventure Youth Explorer Voyage aboard the STS Leeuwin II.

News & Events
Kids 'rock' out at diabetes campDiabetes WA and Perth Children’s Hospital’s recent camp proved to be a “rock-star” hit for kids living with type 1 diabetes.

News & Events
Well done KarenCongratulations to Children's Diabetes Centre exercise researcher Dr Karen Rothacker for receiving the prestigious ADS President’s Clinical Young Investigator Award at the 2018 Australasian Diabetes Congress held in Adelaide recently.

News & Events
Research buddies neededAre you aged 18-40 years and living with T1D? If so, researchers planning a trial comparing different ways of providing diabetes education need feedback.

At CliniKids, we offer group or individual support for siblings of autistic children.
Research
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyWe evaluated the immunogenicity and safety of 1 and 2 doses of MenACWY-TT, given alone or co-administered with PCV13 in toddlers.

A list of the Children's Diabetes Centre's research track record.